Beacon Pharmaceuticals Market Cap

Beacon Pharmaceuticals has a market cap or net worth of 24.72 billion as of February 12, 2026. Its market cap has decreased by -17.88% in one year.

Market Cap

24.72B

Enterprise Value

31.22B

Revenue

11.58B

Ranking

n/a

PE Ratio

43.36

Stock Price

107.00

Market Cap Chart

Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 24.72B, an increase of 24.01%. That is a compound annual growth rate of 1.40%.

Market Cap History

Date	Market Cap	% Change
Feb 10, 2026	24.72B	2.29%
Dec 30, 2025	24.16B	-23.03%
Dec 30, 2024	31.39B	-44.53%
Dec 28, 2023	56.60B	-14.34%
Dec 29, 2022	66.07B	17.50%
Dec 30, 2021	56.23B	210.46%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 27, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Square Pharmaceuticals PLC.	195.91B
Beximco Pharmaceuticals PLC.	54.25B
Renata	53.99B
Unilever Consumer Care	42.71B
The ACME Laboratories	16.12B
The IBN SINA Pharmaceutical Industry	10.82B
Asiatic Laboratories	8.37B
Orion Pharma	6.95B

Market Cap Rankings